FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Broadfin Healthcare Master Fund Ltd   2. Issuer Name and Ticker or Trading Symbol Recro Pharma, Inc. [REPH] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 20 GENESIS CLOSE, ANSBACHER HOUSE, 2ND FLOOR, PO BOX 1344 3. Date of Earliest Transaction (Month/Day/Year) 11/28/2017 (Street) GRAND CAYMAN, E9 KY1-1108 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) ___ Form filed by One Reporting Person _X_ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock, $0.01 par value per share 11/28/2017   S   24,430 D $ 9.71 2,903,448 D (1)   Common Stock, $0.01 par value per share 11/28/2017   S   1,500 D $ 9.68 2,901,948 D (1)   Common Stock, $0.01 par value per share 11/28/2017   S   21,619 D $ 9.56 2,880,329 D (1)   Common Stock, $0.01 par value per share 11/29/2017   S   2,200 D $ 9.68 2,878,129 D (1)   Common Stock, $0.01 par value per share 11/29/2017   S   700 D $ 9.68 2,877,429 D (1)   Common Stock, $0.01 par value per share 11/29/2017   S   3,764 D $ 9.66 2,873,665 D (1)   Common Stock, $0.01 par value per share 11/30/2017   S   6,381 D $ 9.71 2,867,284 D (1)   Common Stock, $0.01 par value per share 11/30/2017   S   100 D $ 9.71 2,867,184 D (1)   Common Stock, $0.01 par value per share 11/30/2017   S   6,322 D $ 9.63 2,860,862 D (1)   Common Stock, $0.01 par value per share 11/30/2017   S   500 D $ 9.69 2,860,362 D (1)   Common Stock, $0.01 par value per share 11/30/2017   S   5,000 D $ 9.62 2,855,362 D (1)   Common Stock, $0.01 par value per share 11/30/2017   S   50,000 D $ 9.55 2,805,362 D (1)   Common Stock, $0.01 par value per share 11/30/2017   S   100,000 D $ 9.55 2,705,362 D (1)   Common Stock, $0.01 par value per share 11/30/2017   S   100 D $ 9.61 2,705,262 D (1)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Broadfin Healthcare Master Fund Ltd 20 GENESIS CLOSE ANSBACHER HOUSE, 2ND FLOOR, PO BOX 1344 GRAND CAYMAN, E9 KY1-1108		X
Broadfin Capital, LLC 300 PARK AVENUE 25TH FLOOR NEW YORK, NY 10022		X
KOTLER KEVIN C/O BROADFIN CAPITAL, LLC 300 PARK AVENUE, 25TH FLOOR NEW YORK, NY 10022		X

Signatures

Broadfin Healthcare Master Fund, Ltd., By: /s/ Kevin Kotler, Director		11/30/2017
**Signature of Reporting Person		Date
BROADFIN CAPITAL, LLC By: /s/ Kevin Kotler, Managing Member		11/30/2017
**Signature of Reporting Person		Date
/s/ Kevin Kotler		11/30/2017
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The Common Stock is held in the account of Broadfin Healthcare Master Fund, Ltd., a private investment fund managed by Broadfin Capital, LLC and may be deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Capital, LLC. Each of Broadfin Capital, LLC, Broadfin Healthcare Master Fund, Ltd. and Kevin Kotler disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and affirmatively disclaim being a "group" for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.